Clinical Trial Update: Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immune checkpoint inhibitors for organ preservation in non-metastatic dMMR/MSI-H gastric or colon cancers; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Gastric Cancer

Snippet

Sponsor: Peking University | Conditions: Gastric Cancer, Colon Cancer | Phase 2 | Status: RECRUITING